Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.8K Sell
85
-15
-15% -$3.33K ﹤0.01% 2093
2026
Q2
$21.2K Buy
100
+16
+19% +$3.43K ﹤0.01% 1987
2026
Q1
$18.7K Sell
84
-5
-6% -$1.22K ﹤0.01% 1741
2025
Q4
$22.7K Buy
89
+8
+10% +$2.01K ﹤0.01% 1699
2025
Q3
$20.1K Sell
81
-4
-5% -$957 ﹤0.01% 1580
2025
Q2
$20.5K Sell
85
-5
-6% -$1.16K ﹤0.01% 1486
2025
Q1
$20.4K Buy
90
+13
+17% +$2.86K ﹤0.01% 1450
2024
Q4
$15.8K Buy
77
+31
+67% +$6.8K ﹤0.01% 1554
2024
Q3
$11.2K Buy
+46
New +$10.8K ﹤0.01% 1698

Other funds holding STE

BFC Planning's STE Position: Q3 2026 in Review

BFC Planning reduced its Steris (STE) stake by 15% in Q3 2026, selling an estimated $3.33K and leaving 85 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2093.

BFC Planning first reported a position in STE in Q3 2024 and has held it in 9 quarters since. The position peaked at $22.7K in Q4 2025. 698 funds tracked by Wall St. Rank hold STE as of Q3 2026.

  • BFC Planning held 85 shares of Steris worth $17.8K as of Q3 2026.
  • BFC Planning sold 15 Steris shares in Q3 2026, an estimated $3.33K.
  • Steris made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2093 holding.
  • BFC Planning first reported a position in Steris in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Steris position peaked at $22.7K in Q4 2025.
  • 698 funds tracked by Wall St. Rank held Steris as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.